Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

PAVmed (PAVM) Shares Issued (2018 - 2025)

PAVmed has reported Shares Issued over the past 5 years, most recently at -$841000.0 for Q4 2025.

For Q4 2025, Shares Issued rose 30.27% year-over-year to -$841000.0; the TTM value through Sep 2025 reached -$365000.0, changed N/A, while the annual FY2024 figure was $62000.0, 76.06% down from the prior year.
Shares Issued for Q4 2025 was -$841000.0 at PAVmed, down from $841000.0 in the prior quarter.
Over five years, Shares Issued peaked at $7.7 million in Q4 2021 and troughed at -$1.2 million in Q4 2024.
A 5-year average of $505400.0 and a median of $131000.0 in 2021 define the central range for Shares Issued.
Biggest five-year swings in Shares Issued: tumbled 7437.5% in 2024 and later skyrocketed 1256.45% in 2025.
Year by year, Shares Issued stood at $7.7 million in 2021, then tumbled by 96.75% to $249000.0 in 2022, then plummeted by 106.43% to -$16000.0 in 2023, then tumbled by 7437.5% to -$1.2 million in 2024, then surged by 30.27% to -$841000.0 in 2025.
Business Quant data shows Shares Issued for PAVM at -$841000.0 in Q4 2025, $841000.0 in Q1 2025, and -$1.2 million in Q4 2024.